蛛网膜下腔出血后的炎症和抗炎靶点。
Inflammation and Anti-Inflammatory Targets after Aneurysmal Subarachnoid Hemorrhage.
机构信息
Department of Neurosurgery, Heinrich-Heine University Medical Center, 40225 Düsseldorf, Germany.
出版信息
Int J Mol Sci. 2021 Jul 8;22(14):7355. doi: 10.3390/ijms22147355.
Abstract
Aneurysmal subarachnoid hemorrhage (aSAH), with a crude worldwide incidence of around 7 [...].
摘要
颅内动脉瘤性蛛网膜下腔出血（aSAH），全球粗发病率约为 7[...]。
相似文献
1
Inflammation and Anti-Inflammatory Targets after Aneurysmal Subarachnoid Hemorrhage.蛛网膜下腔出血后的炎症和抗炎靶点。
Int J Mol Sci. 2021 Jul 8;22(14):7355. doi: 10.3390/ijms22147355.
2
Vasospasm after aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后的血管痉挛
Crit Care Nurse. 2004 Oct;24(5):58-60, 62, 64-7.
3
Effect of premorbid hypertension control on outcome of patients with aneurysmal subarachnoid hemorrhage.高血压病的发病前控制对蛛网膜下腔出血患者结局的影响。
Acta Neurochir (Wien). 2018 Dec;160(12):2401-2407. doi: 10.1007/s00701-018-3699-1. Epub 2018 Oct 12.
4
Aneurysmal subarachnoid haemorrhage in a patient with thyrotoxicosis.一名甲状腺毒症患者发生动脉瘤性蛛网膜下腔出血。
Br J Neurosurg. 2006 Jun;20(3):165-8. doi: 10.1080/02688690600777133.
5
Preliminary results in the analysis of the immune response after aneurysmal subarachnoid hemorrhage.分析颅内动脉瘤性蛛网膜下腔出血后免疫反应的初步结果。
Sci Rep. 2020 Jul 16;10(1):11809. doi: 10.1038/s41598-020-68861-y.
6
Treatment of aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血的治疗
Semin Neurol. 1998;18(4):521-31. doi: 10.1055/s-2008-1040905.
7
Early Hemodynamic Changes Based on Initial Color-Coding Angiography as a Predictor for Developing Subsequent Symptomatic Vasospasm After Aneurysmal Subarachnoid Hemorrhage.基于初始颜色编码血管造影的早期血流动力学变化作为动脉瘤性蛛网膜下腔出血后发生后续症状性血管痉挛的预测指标
World Neurosurg. 2018 Jan;109:e363-e373. doi: 10.1016/j.wneu.2017.09.179. Epub 2017 Oct 5.
8
Cerebral vasospasm patterns following aneurysmal subarachnoid hemorrhage: an angiographic study comparing coils with clips.动脉瘤性蛛网膜下腔出血后的脑血管痉挛模式：一项比较弹簧圈与夹子的血管造影研究
J Neurointerv Surg. 2015 Nov;7(11):803-7. doi: 10.1136/neurintsurg-2014-011374. Epub 2014 Sep 17.
9
Aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血
J Contin Educ Nurs. 2004 Jul-Aug;35(4):150-1. doi: 10.3928/0022-0124-20040701-05.
10
Clinical characteristics and long-term outcomes in patients with ruptured posterior inferior cerebellar artery aneurysms: a comparative analysis.小脑后下动脉破裂性动脉瘤患者的临床特征与长期预后：一项对比分析
J Neurosurg. 2015 Aug;123(2):441-5. doi: 10.3171/2014.10.JNS141079. Epub 2015 Apr 17.
引用本文的文献
1
Constructing a nomogram for short-term prognosis in postoperative patients with aneurysmal subarachnoid hemorrhage: a two-center retrospective study.构建动脉瘤性蛛网膜下腔出血术后患者短期预后的列线图：一项两中心回顾性研究。
Sci Rep. 2025 Aug 1;15(1):28153. doi: 10.1038/s41598-025-11894-y.
2
Acute Neurovascular Inflammatory Profile in Patients with Aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血患者的急性神经血管炎症特征
Biomolecules. 2025 Apr 23;15(5):613. doi: 10.3390/biom15050613.
3
Inflammasome Proteins Are Reliable Biomarkers of the Inflammatory Response in Aneurysmal Subarachnoid Hemorrhage.炎症小体蛋白是蛛网膜下腔出血炎症反应的可靠生物标志物。
Cells. 2024 Aug 17;13(16):1370. doi: 10.3390/cells13161370.
4
Prognostic value of platelet levels in patients with aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血患者血小板水平的预后价值。
Sci Rep. 2024 Jul 20;14(1):16743. doi: 10.1038/s41598-024-67322-0.
5
Causal Relationships Between Gut Microbiota, Inflammatory Cells/Proteins, and Subarachnoid Hemorrhage: A Multi-omics Bidirectional Mendelian Randomization Study and Meta-analysis.肠道微生物群、炎性细胞/蛋白与蛛网膜下腔出血之间的因果关系：一项多组学双向孟德尔随机化研究与荟萃分析
Mol Neurobiol. 2024 Nov;61(11):8590-8599. doi: 10.1007/s12035-024-04101-y. Epub 2024 Mar 25.
6
Perampanel attenuates oxidative stress and pyroptosis following subarachnoid hemorrhage via the SIRT3/FOXO3α pathway.氨己烯酸通过 SIRT3/FOXO3α 通路减轻蛛网膜下腔出血后的氧化应激和细胞焦亡。
Sci Rep. 2023 Dec 3;13(1):21320. doi: 10.1038/s41598-023-48802-1.
7
WTAP affects intracranial aneurysm progression by regulating m6A methylation modification.WTAP通过调节m6A甲基化修饰影响颅内动脉瘤进展。
Open Med (Wars). 2023 Oct 16;18(1):20230818. doi: 10.1515/med-2023-0818. eCollection 2023.
8
Inflammatory Burden Index: Association Between Novel Systemic Inflammatory Biomarkers and Prognosis as Well as in-Hospital Complications of Patients with Aneurysmal Subarachnoid Hemorrhage.炎症负担指数：新型全身炎症生物标志物与动脉瘤性蛛网膜下腔出血患者预后及院内并发症之间的关联
J Inflamm Res. 2023 Sep 4;16:3911-3921. doi: 10.2147/JIR.S416295. eCollection 2023.
9
Should individual timeline and serial CT/MRI panels of all patients be presented in acute brain insult cohorts? A pilot study of 45 patients with decompressive craniectomy after aneurysmal subarachnoid hemorrhage.是否应该在急性脑损伤队列中呈现所有患者的个体时间线和连续 CT/MRI 图？一项对 45 例动脉瘤性蛛网膜下腔出血后去骨瓣减压术患者的初步研究。
Acta Neurochir (Wien). 2023 Nov;165(11):3299-3323. doi: 10.1007/s00701-022-05473-7. Epub 2023 Jan 30.
10
Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway.抑制 CCR2 通过 PI3K/Akt 通路减轻蛛网膜下腔出血后的神经炎症和神经元凋亡。
J Neuroinflammation. 2022 Dec 25;19(1):312. doi: 10.1186/s12974-022-02676-8.
本文引用的文献
1
Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH).动脉瘤性蛛网膜下腔出血（aSAH）的神经保护策略。
Int J Mol Sci. 2021 May 21;22(11):5442. doi: 10.3390/ijms22115442.
2
Role of Adaptor Protein Myeloid Differentiation 88 (MyD88) in Post-Subarachnoid Hemorrhage Inflammation: A Systematic Review.髓样分化因子 88（MyD88）衔接蛋白在后交通动脉瘤破裂后炎症中的作用：系统评价。
Int J Mol Sci. 2021 Apr 18;22(8):4185. doi: 10.3390/ijms22084185.
3
Vascular Macrophages as Therapeutic Targets to Treat Intracranial Aneurysms.血管巨噬细胞作为治疗颅内动脉瘤的治疗靶点。
Front Immunol. 2021 Mar 8;12:630381. doi: 10.3389/fimmu.2021.630381. eCollection 2021.
4
The immune response of T cells and therapeutic targets related to regulating the levels of T helper cells after ischaemic stroke.缺血性脑卒中后 T 细胞免疫反应及调节 T 辅助细胞水平的治疗靶点。
J Neuroinflammation. 2021 Jan 18;18(1):25. doi: 10.1186/s12974-020-02057-z.
5
Role of perivascular and meningeal macrophages in outcome following experimental subarachnoid hemorrhage.实验性蛛网膜下腔出血后血管周和脑膜巨噬细胞的作用。
J Cereb Blood Flow Metab. 2021 Aug;41(8):1842-1857. doi: 10.1177/0271678X20980296. Epub 2021 Jan 14.
6
Mesenchymal stem cell-derived extracellular vesicles promote microglial M2 polarization after subarachnoid hemorrhage in rats and involve the AMPK/NF-κB signaling pathway.间质干细胞衍生的细胞外囊泡促进大鼠蛛网膜下腔出血后小胶质细胞 M2 极化，并涉及 AMPK/NF-κB 信号通路。
Biomed Pharmacother. 2021 Jan;133:111048. doi: 10.1016/j.biopha.2020.111048. Epub 2020 Nov 28.
7
Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH).脑脊液和系统趋化因子 CCL5 水平升高是动脉瘤性蛛网膜下腔出血 (aSAH) 后临床转归的预测生物标志物。
Cytokine. 2020 Sep;133:155142. doi: 10.1016/j.cyto.2020.155142. Epub 2020 May 30.
8
Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review.靶向蛛网膜下腔出血中的高迁移率族蛋白 B1：系统评价。
Int J Mol Sci. 2020 Apr 14;21(8):2709. doi: 10.3390/ijms21082709.
9
Treatment of Spontaneous Subarachnoid Hemorrhage: Guidelines and Gaps.自发性蛛网膜下腔出血的治疗：指南与差距
Stroke. 2020 Apr;51(4):1326-1332. doi: 10.1161/STROKEAHA.119.025997. Epub 2020 Jan 22.
10
Mesenchymal stem cells for hemorrhagic stroke: status of preclinical and clinical research.用于出血性中风的间充质干细胞：临床前和临床研究现状
NPJ Regen Med. 2019 May 13;4:10. doi: 10.1038/s41536-019-0073-8. eCollection 2019.
Zotero 插件